Scientific Archives - Page 2 of 9

Philogen announces enrolment of 214 patients in the Nidlegy™ Phase III European clinical trial for the treatment of locally advanced melanoma

Jul 25, 2022 | 2022, Press Releases, Scientific

More details

Philogen to attend the 3rd Annual Cytokine-Based Drug Development Summit, Boston (July 26-29, 2022)

Jun 27, 2022 | 2022, Past Events, Scientific

Philogen will attend the 3rd Annual Cytokine-Based Drug Development Summit in Boston. Roberto De Luca, Head of Antibody Therapeutics, will give a virtual lecture entitled “Antibody-cytokine fusion proteins against Fibroblast Activation Protein (FAP)” on the 28...

Philogen receives authorisation to initiate new study in France to evaluate Nidlegy™ in several non-melanoma skin cancers

Feb 17, 2022 | 2022, Press Releases, Scientific

More details

Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)

Jan 7, 2022 | 2022, Press Releases, Scientific

More info here

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

Nov 24, 2021 | 2021, Press Releases, Scientific

More datails

Philogen provides Corporate Update

Nov 12, 2021 | 2021, Press Releases, Scientific

Philogen to hold a Webinar at 11 am EST / 4 pm GMT / 5 pm CET on Friday 12th November 2021, Click here to view Press Release 12-11-2021